Latest Insider Transactions at Sensei Biotherapeutics, Inc. (SNSE)
This section provides a real-time view of insider transactions for Sensei Biotherapeutics, Inc. (SNSE). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Sensei Biotherapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Sensei Biotherapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 25
2021
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
12,000
+0.25%
|
$180,000
$15.79 P/Share
|
|
Feb 24
2021
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
19,000
+0.2%
|
$323,000
$17.63 P/Share
|
|
Feb 24
2021
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
19,000
+0.2%
|
$323,000
$17.63 P/Share
|
|
Feb 23
2021
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
20,300
+0.21%
|
$345,100
$17.57 P/Share
|
|
Feb 23
2021
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
20,300
+0.21%
|
$345,100
$17.57 P/Share
|
|
Feb 22
2021
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
9,802
+0.21%
|
$176,436
$18.88 P/Share
|
|
Feb 22
2021
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
9,802
+0.21%
|
$176,436
$18.88 P/Share
|
|
Feb 19
2021
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
11,786
+0.25%
|
$223,934
$19.77 P/Share
|
|
Feb 19
2021
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
11,786
+0.25%
|
$223,934
$19.77 P/Share
|
|
Feb 18
2021
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct |
753
+0.02%
|
$14,307
$19.75 P/Share
|
|
Feb 18
2021
|
James Peyer |
BUY
Open market or private purchase
|
Indirect |
753
+0.02%
|
$14,307
$19.75 P/Share
|
|
Feb 08
2021
|
Cambrian Bio Pharma Inc |
BUY
Conversion of derivative security
|
Direct |
2,407,328
+33.92%
|
-
|
|
Feb 08
2021
|
H&S Investments I LP > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
4,361,835
+49.63%
|
-
|
|
Feb 08
2021
|
James Peyer |
BUY
Conversion of derivative security
|
Indirect |
2,407,328
+33.92%
|
-
|
|
Feb 08
2021
|
Thomas G Ricks |
BUY
Conversion of derivative security
|
Indirect |
301,769
+50.0%
|
-
|